NRI from all over the world (excluding U.S.A. & Canada) can invest in this fund
SBNRI is a certified Mutual Fund distributor registered with Association of Mutual Funds in India (AMFI) with Reg. No. 246671
₹30.72
-0.45%
NAV as on 01 May 24, 12:00 AM
very high risk
sector healthcare
equity
NAV as on 01 May 24, 12:00 AM
very high risk
sector healthcare
equity
57.78%p.a.
Last 1Y
17.70%p.a.
Last 3Y
24.57%p.a.
Last 5Y
21.34%p.a.
Since Inception
About ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth for NRIs
NRIs can achieve long-term capital appreciation by investing in the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth scheme from ICICI Prudential Asset Management Company Limited. It is a Sector - Healthcare mutual fund scheme that predominantly invests in Sector - Healthcare stocks of companies. Launched on Jul 2018, ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth is Sector - Healthcare fund of its category with 3,772.32 Cr fund under management as on Apr 2024. The expense ratio of this fund is less than that of most other Fund category Sector - Healthcare funds.
- ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth delivered 57.8% annual returns during the last year. It has delivered 21.3% average annual returns since the fund was launched.
- ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth scheme tends to consistently deliver higher returns than most schemes in the same category.
- The scheme has predominantly invested in equity
Fund Objective
To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objectives of the scheme would be achieved.
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd
15.24%
Dr Reddy's Laboratories Ltd
7.19%
Divi's Laboratories Ltd
6.68%
Aurobindo Pharma Ltd
6.56%
Apollo Hospitals Enterprise Ltd
6.45%
Lupin Ltd
5.93%
Cipla Ltd
5.31%
Mankind Pharma Ltd
3.38%
Alkem Laboratories Ltd
2.49%
Fortis Healthcare Ltd
2.48%
Fund Managers
- Dharmesh Kakkad (May 2020 - Present)
- Sharmila D’mello (Jul 2022 - Present)
Key Information
View Scheme Document
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth SIP Calculator
If invested
per month
For a period of
Investment of ₹0 could have been
₹0(+0.0%)
₹0 (+0.0%)
This Fund
₹0 (+0.0%)
Fixed Deposit
NRI Mutual Fund Tax on ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
Just like for resident investors, capital gains from mutual fund investments are subject to income tax for NRI investors.
| Fund Type | Short-term Capital Gains (STCG) Tax | Long-term Capital Gains (LTCG) Tax |
|---|---|---|
| Equity mutual funds | 15% | 10% (above Rs. 1 lakh LTCG) without indexation* |
| Debt & other types of funds | At tax slab rate | 20% with indexation benefits |
How can NRIs invest in ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth?
NRIs and OCIs can download the SBNRI app to invest in mutual funds from the country of their residence. Here are a few simple steps you need to take:
- Complete your NRI KYC: Type in your personal details and attach supporting documents, like:
- PAN Number
- Overseas address proof: Any of – Water/electricity bill, postpaid mobile/internet bill, rent agreement, driving license, etc.
- Passport – front and back
- Passport size photograph
- signature
If all details are correct, your KYC will be approved within 7 to 8 business days.
- Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing in ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
- Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing:
- City and country of birth
- NRE/NRO bank account statement/ canceled cheque for the latest 3 months
- Nominee details
Similar Funds
Funds
3Y Return
Nippon India Pharma Fund - Growth
very high risk | equity
15.7%
SBI Healthcare Opportunities Fund Growth
very high risk | equity
17.6%
DSP Healthcare Fund Growth
very high risk | equity
16.6%
Frequently Asked Questions
Copyright | 2021 @ SBNRI | All Rights Reserved